Impax Asset Management Group’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Impax Asset Management Group's DGX Position: Q1 2024 in Review
Impax Asset Management Group sold out of Quest Diagnostics (DGX) in Q1 2024, closing a stake of 2,592 shares — an estimated $357K sold.
Impax Asset Management Group first reported a position in DGX in Q3 2018 and held it in 21 quarters. The position peaked at $25.7M in Q2 2021. 819 funds tracked by Wall St. Rank hold DGX as of Q1 2024.
- Impax Asset Management Group reported no remaining Quest Diagnostics position as of Q1 2024 after selling out during the quarter.
- Impax Asset Management Group sold 2,592 Quest Diagnostics shares in Q1 2024, an estimated $357K.
- Impax Asset Management Group first reported a position in Quest Diagnostics in Q3 2018 and held it in 21 quarters.
- Impax Asset Management Group's Quest Diagnostics position peaked at $25.7M in Q2 2021.
- 819 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.
Based on Impax Asset Management Group's 13F filing for Q1 2024, filed 30 Apr 2024.